Fees

Cost recovery is a federal government policy intended to promote more business-like and equitable management of government programs. The policy stipulates that specific individuals or firms, who benefit directly from or cause government activity should bear some or all of the cost of those activities.

Most Therapeutic Products Directorate (TPD) regulatory activities represent a direct benefit to or are triggered by companies selling therapeutic products on the Canadian market; therefore, these activities are considered appropriate for cost recovery.

	Annual Authority to Sell
	Drug Master File Fees
	Establishment Licence Fees
	Submission Evaluation Fees

Annual Authority to Sell

Authority to Sell Drug Fees, Fee Reductions and Adjustment Requests Date: 2007-05-07

Drug Master File Fees

	It should be noted that the "DMF Application Fee Form" contained within this document has been updated. Please refer to the following for the current version. Date: 2004-09-29
	Drug Master File Fees Date: 1996-01-01

Establishment Licence Fees

	Guidance Document on Drug Establishment Licences and Establishment Licensing Fees Date: 1996-12-18
	Drug Establishment Licence : Fee Reduction Request Date: 2007-08-08

Submission Evaluation Fees

Cost Recovery Submission Evaluation Fees Date: 1998-05-01